UroLift Clinical Trials
2 recruitingDevice
Not Applicable2
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Post-Market Study to Assess iTind Safety in Comparison to UroLift
Benign Prostatic Hyperplasia (BPH)
Olympus Corporation of the Americas206 enrolled19 locationsNCT04757116
Recruiting
Not Applicable
Comparing Rezum and Urolift
Prostate Cancer
Chinese University of Hong Kong120 enrolled1 locationNCT06820606